Picture courtesy newsd.in
London: The Oxford-AstraZeneca COVID-19 vaccine is 67 per cent effective in reducing the spread of the virus after a single shot, a study published in the Lancet said.
A two-dose regimen brings efficacy to 50 per cent.
The vaccine also shows 76 per cent efficacy against symptomatic infection after 90 days of a single shot, AstraZeneca said on Wednesday. The efficacy increased to 82 per cent after inter-dose interval of 12 weeks or more.
This helps support the policy recommendation in the UK to immunize more people at one go by delaying the second dose.
This analysis for efficacy was based on 17,177 participants including 332 symptomatic cases from Phase 3 trials led by Oxford University and AstraZeneca in UK, Brazil and South Africa. It showed that there were no severe cases and no hospitalization, more than 22 days after the first dose.
Bargarh: A new artist will be selected to play the mythological character King Kansa during…
Mumbai: Suhana Khan will be making her Bollywood debut with ‘King’ along with her superstar…
New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…
New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…
Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…